AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7778813
Drug: Cephalosporine 2
RxNorm normalized name: Cephalosporium roseum
DrugBank: Cephalosporium roseum (DB10932)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalosporine 2 (2-day treatment)
Trial: 7778813
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics for clean, planned surgery (grade II)
Trial: 2531557
Drug: 10 micrograms.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms.kg‐1 sufentanil as an induction dose plus 0.15 microgram.kg‐1.min‐1 continuous infusion
Trial: 2531557
Drug: 10 micrograms.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms.kg‐1 sufentanil as an induction dose plus 0.3 microgram.kg‐1.min‐1 continuous infusion
Trial: 21575503
Drug: L‐OHP +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐OHP + CAP (oxaliplatin plus capecitabine)
Trial: 15119989
Drug: GAL 24
RxNorm normalized name: Nasopro 24
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: GAL 24 mg (12 mg BID)
Trial: 15119989
Drug: GAL 16
RxNorm normalized name: QUATERNIUM-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GAL 16 mg (8 mg BID)
Trial: 9773664
Drug: Tirilazad mesylate
RxNorm normalized name: tirilazad mesylate
DrugBank: Tirilazad (DB13050)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirilazad mesylate 6 mg/kg/day for 10 days
Trial: 8064733
Drug: S-adenosylmethionine (SAM)
RxNorm normalized name: S-adenosylmethionine
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosylmethionine (SAM) intravenous boluses of 400 mg for 5 days, followed by oral tablets, 200 mg thrice daily for 23 days
Trial: 3069750
Drug: Fenticonazole vaginal
RxNorm normalized name: fenticonazole
DrugBank: Fenticonazole (DB13434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenticonazole vaginal ovules 200 mg
Trial: 3069750
Drug: Fenticonazole vaginal
RxNorm normalized name: fenticonazole
DrugBank: Fenticonazole (DB13434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenticonazole vaginal ovules 600 mg
Trial: 3069750
Drug: Fenticonazole vaginal
RxNorm normalized name: fenticonazole
DrugBank: Fenticonazole (DB13434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenticonazole vaginal ovules 1,000 mg
Trial: 29078966
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) on PC6 acupuncture point
Trial: 18275361
Drug: Compressed air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compressed air massage (15-20 min daily at 1 bar pressure, 5 days a week)
Trial: 11916198
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy (6 MIU interferon-alpha-2a daily for 4 weeks followed by 3 MIU thrice weekly for 22 weeks)
Trial: 11916198
Drug: Standard interferon
RxNorm normalized name: INTERFERON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard interferon therapy (3 MIU interferon-alpha-2a thrice weekly for 26 weeks)
Trial: 11916198
Drug: Standard interferon
RxNorm normalized name: INTERFERON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard interferon therapy
Trial: 10091835
Drug: Meal rich
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal rich in used cooking fat (fat 64.4 g)
Trial: 10091835
Drug: Meal rich
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal rich in unused cooking fat (fat 64.4 g)
Trial: 10091835
Drug: Low fat
RxNorm normalized name: Low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fat meal (fat 18.4 g)
Trial: 1398465
Drug: GH-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH-releasing hormone (GHRH)
Trial: 7208542
Drug: Iron poly
RxNorm normalized name: iron polymaltose
DrugBank: Iron polymaltose (DB15763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron poly (sorbitol‐gluconic acid) complex (IPSG) 250 mg elemental iron per week for 8 weeks
Trial: 7208542
Drug: Iron poly
RxNorm normalized name: iron polymaltose
DrugBank: Iron polymaltose (DB15763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron poly (sorbitol‐gluconic acid) complex (IPSG) 500 mg elemental iron per week for 8 weeks
Trial: 6831362
Drug: Levamisole (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (45 mg/m2, orally, twice daily for three consecutive days each week)
Trial: 6831362
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (daunorubicin and cytosine arabinoside for induction and consolidation, methotrexate with citrovorum factor reversal, thioguanine and cytosine arabinoside for late intensification)
Trial: 26196201
Drug: 10,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10,000 IU of oral vitamin D3/10 kg body weight per week for 6 weeks
Trial: 26196201
Drug: 5000 IU
RxNorm normalized name: D 5000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 IU of oral vitamin D3/10 kg body weight per week for 6 weeks
Trial: 25012515
Drug: CX157 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CX157 treatment
Trial: 22273828
Drug: Ramosetron 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramosetron 6 μg/kg
Trial: 22273828
Drug: Ramosetron 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramosetron 6 μg/kg and midazolam 0.1 mg/kg
Trial: 17919233
Drug: High-dose PegIFN-alpha-2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose PegIFN-alpha-2b (3.0 microg/kg once weekly for 12 weeks, then 2.0 microg/kg once weekly for 12 weeks, then 1.5 microg/kg once weekly for 48 weeks)
Trial: 17919233
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen of PegIFN-alpha-2b (1.5 microg/kg once weekly for 48 weeks)
Trial: 15619603
Drug: Ketoprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (100 mg) before induction of anaesthesia (group K1)
Trial: 15619603
Drug: Propacetamol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propacetamol (2 g) before induction of anaesthesia (group P1)
Trial: 15619603
Drug: Saline before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline before surgery and ketoprofen (100 mg) after surgery (group K2)
Trial: 15619603
Drug: Saline before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline before surgery and propacetamol (2 g) after surgery (group P2)
Trial: 10088167
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray (large-particle aerosol)
Trial: 465281
Drug: Aspirin (1280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1280 mg each)
Trial: 465281
Drug: Dimenhydrinate (Dramamine)
RxNorm normalized name: Dimenhydrinate
DrugBank: Dimenhydrinate (DB00985)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dimenhydrinate (Dramamine) (100 mg each)
Trial: 2178493
Drug: Intramuscular clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular clonidine (2 micrograms/kg)
Trial: 6775303
Drug: pentaerythritol tetranitrate
RxNorm normalized name: Pentaerythritol tetranitrate
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pentaerythritol tetranitrate (PETN) 80 mg 8-hourly
Trial: 6775303
Drug: dipyramidole (DPM)
RxNorm normalized name: DPM-1001
DrugBank: DPM-1001 (DB18390)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dipyramidole (DPM) 75 mg
Trial: 26553159
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment (24 weeks)
Trial: 26553159
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (24 weeks)
Trial: 15246912
Drug: SLV306 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLV306 (200 mg)
Trial: 15246912
Drug: SLV306 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLV306 (400 mg)
Trial: 15246912
Drug: SLV306 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLV306 (800 mg)
Trial: 15246912
Drug: SLV306 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLV306 (all doses)
Trial: 9509213
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (Group B)
Trial: 3289804
Drug: Immunosuppressants (corticosteroids,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressants (corticosteroids, cyclophosphamide, azathioprine)
Trial: 3289804
Drug: Immunosuppressants (corticosteroids,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressants (corticosteroids, cyclophosphamide, azathioprine) + Plasma exchange therapy
Trial: 25633123
Drug: Accelerated Ponseti
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated Ponseti technique (casting twice a week)
Trial: 20874740
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) 0.25 mg/kg twice daily at postnatal day 1 and 2
Trial: 18929194
Drug: Anterior transposition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anterior transposition (subcutaneous or submuscular)
Trial: 15011734
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal patches (17.5 mg/day)
Trial: 8339079
Drug: Topical PROCUREN
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical PROCUREN (autologous platelet-derived wound healing factors)
Trial: 26557261
Drug: Fluticasone (FP)
DrugBank: Fluticasone (DB13867)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone (FP) 500 µg bid, five doses total
Trial: 23497111
Drug: MTX responders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX responders (triple therapy)
Trial: 18343702
Drug: 24-hour therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour therapy with artesunate/sulfamethoxypyrazine/pyrimethamine (As/SMP)
Trial: 18343702
Drug: 3-day therapy
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-day therapy with artesunate/sulfamethoxypyrazine/pyrimethamine (As/SMP)
Trial: 16417952
Drug: MCV-4 (meningococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCV-4 (meningococcal diphtheria toxoid conjugate vaccine)
Trial: 16417952
Drug: Hib vaccine
RxNorm normalized name: ActHIB vaccine 0.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hib vaccine (control group)
Trial: 8193732
Drug: Felodipine 5-20
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5-20 mg orally once daily for 8 weeks
Trial: 8193732
Drug: Enalapril 5-20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5-20 mg orally once daily for 8 weeks
Trial: 31965734
Drug: Trauma-focused therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused therapy (TFT)
Trial: 31350967
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (50,000 IU weekly for 2 months)
Trial: 26179985
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment group received a single shockwave treatment with 1000 impulses at 0.19-0.23 mJ/mm²
Trial: 25163030
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 supplement (daily)
Trial: 19816204
Drug: Low propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low propofol (4 mg/kg/h)
Trial: 19816204
Drug: High propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High propofol (6 mg/kg/h)
Trial: 16187808
Drug: Interactive Voice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive Voice Response (IVR) system for daily reports of cigarette use.
Trial: 16187808
Drug: Timeline Follow-Back
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Timeline Follow-Back (TLFB) method for daily reports of cigarette use.
Trial: 12042274
Drug: Day 5
RxNorm normalized name: One-A-Day 50+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day 5 inhibin B >400 pg/ml
Trial: 12042274
Drug: Day 5
RxNorm normalized name: One-A-Day 50+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day 5 inhibin B <400 pg/ml
Trial: 6350616
Drug: Ceftazidime 250
RxNorm normalized name: ceftazidime 250 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 250 mg administered intramuscularly every 12 hours
Trial: 6350616
Drug: Ceftazidime 500
RxNorm normalized name: ceftazidime 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 500 mg administered intramuscularly every 12 hours
Trial: 6350616
Drug: Ceftazidime 1000
RxNorm normalized name: ceftazidime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 1000 mg administered intramuscularly every 12 hours
Trial: 20004036
Drug: Taking anti-hypertensive
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taking anti-hypertensive medication
Trial: 16316359
Drug: Oral paricalcitol
RxNorm normalized name: Paricalcitol
DrugBank: Paricalcitol (DB00910)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral paricalcitol (mean dose 9.5 microg/week)
Trial: 9689834
Drug: Steroids (previous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids (previous treatment)
Trial: 8075780
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) carbimazole 60 mg plus thyroxine 100-150 micrograms daily
Trial: 8075780
Drug: Titration-dose (TD)
RxNorm normalized name: triamcinolone diacetate Injectable Suspension [TDS Forte]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration-dose (TD) carbimazole
Trial: 8075780
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) and Titration-dose (TD) regimens
Trial: 31544547
Drug: History of
RxNorm normalized name: BEMOTRIZINOL 0.8 mL in 100 mL / OCTINOXATE 7 mL in 100 mL TOPICAL CREAM [THE HISTORY OF WHOO GONG JIN HYANG HAE YOON SUN]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: History of transcatheter arterial chemoembolization (TACE) treatment
Trial: 29221779
Drug: 9-g sodium
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 9-g sodium oxybate (SXB)/nightly
Trial: 29221779
Drug: 200-600 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200-600 mg/d modafinil
Trial: 21316259
Drug: Paravertebral block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paravertebral block (PVB) group (n=20) - 15 ml of ropivacaine 0.2% every 6h combined with endovenous metamizol (1g)
Trial: 21316259
Drug: Alternate NSAIDs
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate NSAIDs group (AN) (n=20) - Paracetamol (1g) combined with metamizol (1g) every 6h
Trial: 20055118
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg b.i.d.
Trial: 20055118
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg q.d.
Trial: 11752357
Drug: Aspirin (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81 mg every morning) before ibuprofen (400 mg every morning)
Trial: 11752357
Drug: Aspirin (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81 mg every morning) before acetaminophen (1000 mg every morning)
Trial: 11752357
Drug: Aspirin (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81 mg every morning) before rofecoxib (25 mg every morning)
Trial: 11752357
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin before ibuprofen (400 mg three times a day)
Trial: 11752357
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin before delayed-release diclofenac (75 mg twice daily)
Trial: 11752357
Drug: Aspirin (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81 mg every morning) after ibuprofen (400 mg every morning)
Trial: 11752357
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily doses of ibuprofen before aspirin
Trial: 9407270
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) for OCD, consisting of 12 weekly sessions.
Trial: 3814463
Drug: Sulindac (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac (200 mg)
Trial: 3814463
Drug: Piretanide (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide (6 mg)
Trial: 3814463
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg) with Hydrochlorothiazide (100 mg)
Trial: 3814463
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg) with Piretanide (6 mg)
Trial: 3814463
Drug: Sulindac (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac (200 mg) with Hydrochlorothiazide (100 mg)
Trial: 3814463
Drug: Sulindac (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac (200 mg) with Piretanide (6 mg)
Trial: 29538682
Drug: Single vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single vaccination with quadrivalent inactivated influenza vaccine (QIV)
Trial: 29538682
Drug: Booster vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster vaccination with quadrivalent inactivated influenza vaccine (QIV)
Trial: 28018112
Drug: Repeated capsaicin
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Repeated capsaicin infusion
Trial: 28018112
Drug: Acute capsaicin
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute capsaicin infusion
Trial: 24659021
Drug: Lenalidomide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide (10 mg × 7 days) alone
Trial: 24659021
Drug: Lenalidomide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide (10 mg × 7 days) with digoxin (0.5 mg on Day 5)
Trial: 24659021
Drug: Lenalidomide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide (25 mg single dose) alone
Trial: 24659021
Drug: Quinidine (300-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (300-600 mg twice-daily × 5 days) plus lenalidomide (on Day 4)
Trial: 24659021
Drug: Temsirolimus (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus (25 mg single dose) alone
Trial: 24659021
Drug: Lenalidomide plus
RxNorm normalized name: Lenalidomide
DrugBank: Lenalidomide (DB00480)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lenalidomide plus temsirolimus (25 mg single dose)
Trial: 22572767
Drug: Donepezil 23
RxNorm normalized name: donepezil 23 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 23 mg/day with memantine
Trial: 22572767
Drug: Donepezil 23
RxNorm normalized name: donepezil 23 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 23 mg/day without memantine
Trial: 22572767
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg/day with memantine
Trial: 22572767
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg/day without memantine
Trial: 18425522
Drug: Intravitreal triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal triamcinolone acetonide (IVTA) injection
Trial: 25837212
Drug: Lifestyle modification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle modification (LSM) with 80g pistachios daily for 3 months
Trial: 21724564
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (loading dose 1 g over 10 minutes, then infusion of 1 g over 8 hours)
Trial: 15848673
Drug: Complete steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete steroid avoidance (standard therapy without steroid induction/maintenance)
Trial: 15848673
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (tacrolimus, mycophenolate mofetil, steroid induction/maintenance)
Trial: 15848673
Drug: Complete steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete steroid avoidance
Trial: 11999667
Drug: BH4 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BH4 (1 mg/min)
Trial: 8672316
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine 1 ml kg‐1 with clonidine 2 micrograms kg‐1
Trial: 8672316
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine 1 ml kg‐1 with adrenaline 5 micrograms ml‐1 (1/200,000)